FDA Inspection 1294396 — Biom Pharmaceutical Corporation

Biom Pharmaceutical Corporation — FEI 3013895030

The FDA completed an inspection of Biom Pharmaceutical Corporation on November 18, 2025 in Sarasota, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 18, 2025
Fiscal Year
2026
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Sarasota, FL (United States)

Citations

IDCFRDescription
1586121 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
1586921 CFR 111.75(c)Specifications met - verify; finished batch
2284321 CFR 111.70(b)Specifications - components
2284721 CFR 111.70(e)Specifications - finished dietary supplement
2289021 CFR 111.260Batch record - required information